Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Weiland, Thomas; Eckert, Alexander; Tomazic, Peter Valentin et al.
DRH1 - a novel blood-based HPV tumour markerEBIOMEDICINE. Bd. 56. 2020
Viardot, Andreas; Hess, Georg; Bargou, Ralf C. et al.
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphomaLEUKEMIA & LYMPHOMA. 2020
Faehling, Martin; Schumann, Christian; Christopoulos, Petros et al.
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)LUNG CANCER. Bd. 150. 2020 S. 114-122
Becker, Cornelia; Graf, Norbert; Grabow, Desiree et al.
Early deaths from childhood cancer in Germany 1980-2016CANCER EPIDEMIOLOGY. Bd. 65. 2020
Kadioglu, Onat; Saeed, Mohamed E. M.; Munder, Markus et al.
Effect of ABC transporter expression and mutational status on survival rates of cancer patientsBIOMEDICINE & PHARMACOTHERAPY. Bd. 131. 2020
Huang, Kui; Madison, Terri; Wehler, Beatrice et al.
Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in EuropePHARMACOLOGY RESEARCH & PERSPECTIVES. Bd. 8. H. 2. 2020
Gkika, Eleni; Lenz, Stefan; Schimek-Jasch, Tanja et al.
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan TrialCANCERS. Bd. 12. H. 11. 2020
Rodriguez-Alvarez, Marta; Kim, Daria; Khobta, Andriy
EGFP Reporters for Direct and Sensitive Detection of Mutagenic Bypass of DNA LesionsBIOMOLECULES. Bd. 10. H. 6. 2020
Stege, H.; Schneider, S.; Forschner, A. et al.
eHealth Competence and Internet Use of Patients with malignant Melanoma: A prospective Study by the Supportive Therapy Committee of the Dermatological Oncology Working Group and the Working Group on Prevention and Integrative Oncology (PRiO) of the German Cancer Society (DKG)JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 18. 2020 S. 22-22
Almstedt, K.; Mendoza, S.; Battista, M. J. et al.
EndoPredict (R) in early hormone receptor-positive, HER2-negative breast cancer: Impact on clinical decisions and clinico-pathological factors influencing its applicationGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 80. H. 10. 2020 S. E93-E93